// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Investigating epigenetic loci implicated in Alzheimer’s disease via the CRISPR-Cas9 system.

Michael Schrauben - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

A high-performance biomarker panel for Alzheimer’s disease screening and staging identified by large-scale plasma proteomic profiling

Yuanbing JIANG - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Metabolomics analysis of the Finnish Geriatric Intervention Study to prevent cognitive impairment and disability (FINGER)

Alina Solomon - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Plasma biomarkers distinguish clinical diagnostic groups in memory clinic patients

Michelle Gerards - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Plasma biomarkers for the AT(N) classification and for the detection of Alzheimer’s disease

Daniel Alcolea - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

The impact of the COVID-19 pandemic on cognitive health

Helen Brooker - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Alterations in olfaction-related brain regions in the ageing population: a structural MRI study

Majed AlOtaibi - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Associations between Obstructive Sleep Apnea, Alzheimer’s Disease Pathology, and Objective Daytime Sleepiness Measured by the Psychomotor Vigilance Task in Cognitively Unimpaired Adults

David T Plante - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Characterization of the NIA-AA Research Framework stage 2 in the longitudinal multicenter DELCODE study

Lena Sannemann - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Depressive symptoms in cognitively unimpaired older adults are associated with decreased structural and functional integrity in the limbic network.

Edelweiss Touron - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Gender differences in the moderating capacity of reserve and resilience factors on the association of Alzheimer’s disease brain pathology and cognitive function

Chinedu T. Udeh-Momoh - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Self-reflection is associated with markers of Alzheimer’s disease in cognitively unimpaired older adults.

Harriet Demnitz-King - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Incidence and prevalence of coexistent retinal diseases and cognitive impairment or dementia: a systematic review

Ying Xu - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Social functioning and cognitive impairment among the oldest old

Inna Lisko - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Spatiotemporal trends in dementia-associated deaths, what do the data reveal?

Luisa Parkinson - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

ATN classification in Dementia with Lewy Bodies: association with clinical profile, cognitive decline and survival

Marleen van de Beek - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Lewy body dementia

N/A

Inflammatory, degeneration and neuritic growth biomarkers predict cognitive decline and dementia in Parkinson’s disease

Sara Hall - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Motoric cognitive risk syndrome: its prognostic value for dementia and other adverse age-related health outcomes. A systematic review

Donncha S Mullin - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Predicting institutionalization and mortality across the spectrum of Alzheimer’s Disease

Arenda Mank - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

White matter hyperintensities

N/A

Prediction of Amyloid-Positivity in Individuals with Subjective Cognitive Decline – Machine Learning Approaches to Optimize Number-Needed-To-Screen

Derya Sahin - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved